Jonathan's practice focuses on patent and IP litigation and strategy.
Experience
Representative matters
Representative matters
Advising Abbott Laboratories and the Europe-based inventors of Humira on certain European aspects of the primary US patent litigation on its biologic Humira, principally relating to the evidence of the invention of Humira and the attack by Centocor on the inventiveness and validity of the patents.
Advising a leading specialist antibody company on patent infringement assertions against its high affinity sheep monoclonal antibody clinical diagnostic test used for vitamin D immunoassays, and formulating strategies for offensive revocation/DNI litigation and European Patent Office opposition. This matter settled favourably on a license basis.
Advising a global life sciences company on pan-European and global defensive and offensive strategies against its principal competitors for a major new biologic, including; optimising its patent portfolio, preparing for offensive revocation/DNI litigation (and injunctions) against competitors, preparing for defensive infringement litigation, preparing European Patent Office strategies, litigation input into optimising patent filings.
Advising Abbott Laboratories and the Europe-based inventors of Humira on certain European aspects of the primary US patent litigation on its biologic Humira, principally relating to the evidence of the invention of Humira and the attack by Centocor on the inventiveness and validity of the patents.
Advising a leading specialist antibody company on patent infringement assertions against its high affinity sheep monoclonal antibody clinical diagnostic test used for vitamin D immunoassays, and formulating strategies for offensive revocation/DNI litigation and European Patent Office opposition. This matter settled favourably on a license basis.
Advising a global life sciences company on pan-European and global defensive and offensive strategies against its principal competitors for a major new biologic, including; optimising its patent portfolio, preparing for offensive revocation/DNI litigation (and injunctions) against competitors, preparing for defensive infringement litigation, preparing European Patent Office strategies, litigation input into optimising patent filings.
Acting in major patent litigation on opioids – part of major pan-European litigation fought in nine countries (and the European Patent Office), and concerning a market with a value of over €500 million. The English litigation was the lead case across Europe. The whole case was successfully brought to a conclusion in record time for a pharma case of ten months from beginning to end of the trial phase (Patents Court) and the appeal phase (Court of Appeal) within a further 10 weeks.
Acting for UCB SA in litigation to prevent the parallel importation of patented and trade marked pharmaceuticals into the UK (principally its third generation antihistamine ZIRTEK/ZYRTEK).
Advising a major European multinational on the UK/European launch of a major new weight loss treatment, and dealing with competitors’ attempts to spoil it.
Advising major pharmaceutical clients on various sets of injunction proceedings and on infringement and validity of patents covering numerous market-leading drugs and planned UK launches of pharmaceutical products.
Advising medical device clients on products ranging from lithotripters through intra-ocular lenses, and surgical instruments to advanced surgical devices and wound care products.
Basic Research v. Allergan – acting for the applicant for cancellation of the BOTOX UK and CTM trade marks on the ground that the mark BOTOX had become generic and in comparative advertising litigation relating to the efficacy of the relevant products as medicinal products. This settled very favourably just before trial.
Merck v. Primecrown – acting in this leading UK/EU case on infringement and exhaustion of rights in patented pharmaceuticals.
Bayer v. Winter (No. 2) – acting in this UK patent infringement case which made new law on the revival of the ne exeat regno sovereign prerogative as an extension of the interim injunction system, and on the confidentiality club regime for use of confidential documents in litigation.
Advising Shanks Group Plc and Ecodeco SRL in patent litigation against United Utilities Plc on a method for biological waste treatment which formed the core technology in a £850 million PPP project.
Acting for the Home Office and the Secretary of State for the Home Department as lead IP lawyer on the transfer to a Government owned company of the Forensic Science Service and its assets (principally an extensive portfolio of DNA-based biotech patents for crime detection and a portfolio of high-tech databases for crime detection and security equipment).
Sabaf S.p.A. v. MFI and Meneghetti S.p.A – acting in the UK Supreme Court, which made new law on the test for obviousness of a patent and collocation, and on importation as an act of patent infringement.
Merrill Lynch Inc's Application – acting in litigation on the patentability of software and business methods in dealing systems. This Court of Appeal decision is the leading UK authority in this field, has been adopted by the EPO Boards of Appeal, and remains the current approach of the EPO to such patents.
Advising a Fortune 500 technology company specialising in internet-related services and products in a patent dispute on its market-leading on-line mapping technology.
Advising a leading European satellite broadcaster on a pan-European dispute on the technology in its customer set top boxes.
Acting for a world-leading biometric tracking and analysis provider in elite sports on a trade secrets dispute concerning its technology.
Acting for Ffastfill PLC in UK and U.S. patent litigation concerning its market leading futures and options derivatives software.
Apple Inc. – successfully defending a patent, design and copyright claim by a well known English inventor that he had invented the iPod and its control mechanism/interface, and the concept of the iPod interrelationship with iTunes.
Acting for Barclays Bank PLC in revocation of the various UK and EP patents protecting the UK ATM network so that Barclays could roll out its own national ATM system.
Acting for Smurfit Kappa Group PLC in patent litigation against DuPont on validity, infringement and patent threats. This included one of the largest patent damages enquiry hearings to be conducted in the UK.
Nikken Kosakusho Works v. Pioneer Trading – acting for the successful defendant in a series of reported judgments that made new law on post-revocation patent amendment (Court of Appeal), interpretation of subjective claims language (Patents Court), and on costs awards on interim injunctions (Patents Court).
Kastner v. Rizla – acting in this Court of Appeal case which made new law on patent construction and obviousness.
Acting on trade secrets litigation for steel supply company brought against its world leading electro discharge technology for texturing rolling mill rolls, which resulted in a comprehensive victory and vindication for the client.
Acting in multinational patent litigation for a specialist close range digital photogrammetry company concerning its real time systems used in the automobile, aerospace, and manufacturing industries.
Advising the Home Office and Secretary of State for the Home Department as lead IP lawyer in relation to the National Identity Card Programme (this is the highly publicized biometric programme that – until cancelled by the Coalition Government – was intended to be implemented nationally across the UK as the country's first mandatory identity card for 60 years). The advice related to the chips, readers and biometric/face recognition technology, and physical security features for the cards.
Acting for the United Kingdom Passport Service as lead IP lawyer in connection with the £550 million procurement, design and deployment of patented technology and other IP for the United Kingdom's new biometric passports (especially in relation to the chips, readers and biometric/face recognition technology, and physical security features for the passports).
Acting in multi-jurisdictional patent litigation on lubricants (Lubrizol Corp v. Esso Petroleum).
Acting in a series of confidential private arbitrations on gas-injected secondary recovery equipment and associated methods.
Acting in a confidential private arbitration arising from a joint venture patent license between two of the world’s leading producers on the use of biofuel feedstock hydrogenation, and the parties’ entitlements to own, patent and exploit the resulting products.
Advising in a confidential global patent licensing programme on the use of in-line pumps to boost the movement of oil and gas.
Acting in patent litigation on liquid explosives for drilling applications.
Acting for Daimler-Chrysler in trade mark litigation on its solar-electric technology.
Comparative advertising: acting for Barclays in the first UK case on comparative advertising (Barclays Bank v. Advanta).
Shape trade marks: acting in one of the EU's leading cases on the registerability of shape trade marks (Dualit Limited’s Application).
Movie titles: acting in a confidential private mediation between two of the world’s largest studios on the rights in the title for one of the largest film franchises.
Broadcasting: acting for Canal+ in a series of multinational disputes – both litigation and arbitrations – on broadcasting carriage and distribution agreements.
Trade mark Reliance Water Controls v. Altecnic Limited – acting for the successful claimant in the UK Supreme Court on the legality of amendments to pending trade mark applications and the status of the classification system.
Coca-Cola Beverages PLC – Hellenic Bottling Company SA – acting as lead IP lawyer on Hellenic Bottling's $4.2 billion merger with Coca-Cola Beverages and its subsequent joint listing in London and Athens.
Acting for Oxford University and one of its senior Professors in relation to copyright infringement claims in a major new textbook.
Recognitions
- Ranked in World Trademark Review (WTR) 1000, 2024-2025
- Selected through peer review for inclusion in The Best Lawyers™ in the United Kingdom for Intellectual Property Law, 2009-2025
- Named "Notable Practitioner" by Managing Intellectual Property, 2023-2024
Credentials
Education
Education
- University of Oxford, 1983, M.A.
Professional admissions & qualifications
Professional admissions & qualifications
- England and Wales
- Ireland
Professional affiliations
Professional affiliations
- Associate of the Chartered Institute of Patent Agents (CIPA)
- Associate of the Institute of Trade Mark Agents (ITMA)
- Member of the International Trademark Association (INTA)
- Member of the International Association for the Protection of Industrial Property (AIPPI)
- Member of the United Kingdom Department of Trade & Industry official delegation to the BioMed conference 2009
News
1 / 14
Blogs
Notable Quotes
- 24 November 2016 "China breaks patent application record" BBC News